Bristol-Myers shares tumble 10% on failed clinical trial https://t.co/qN8olTCboP via @FT
— The Propell Group (@ThePropellGroup) October 12, 2016
#healthtech
Bristol-Myers shares tumble 10% on failed clinical trial https://t.co/qN8olTCboP via @FT
— The Propell Group (@ThePropellGroup) October 12, 2016
#healthtech